Tirzepatide Online | GLP-1 Weight Loss | FRAME Medicine
FRAME Medicine › Tirzepatide
GLP-1 Weight Loss Therapy

Serious Weight Loss.
Serious Physician.

Tirzepatide targets two hormones responsible for hunger, blood sugar, and fat storage. Physician-prescribed, compounded, and shipped to your door. Starting at $69/week.

The Process

From Labs to
Results

01
πŸ“‹
Questionnaire
Complete a short health history. We need to understand your current medications, past conditions, and weight loss goals before evaluating your candidacy.
02
πŸ§ͺ
Labs & Review
$100 covers bloodwork and Dr. Sheffield’s full physician review. He evaluates your metabolic panel, baseline markers, and overall health picture before prescribing.
03
πŸ’Š
Prescription & Shipment
If you’re a candidate, your tirzepatide is compounded by a licensed pharmacy and shipped discreetly to your door with all supplies included.
04
πŸ“ˆ
Titration & Monitoring
Tirzepatide is dose-titrated over time. Dr. Sheffield monitors your response, adjusts dosing, and conducts follow-up labs at appropriate intervals to ensure safety and results.
Why Tirzepatide

The Most Effective
GLP-1 Available

🎯
Dual Receptor Action
Tirzepatide activates both GIP and GLP-1 receptors β€” a mechanism that produces greater weight loss than single-receptor GLP-1 agents like semaglutide in head-to-head clinical data.
βš–οΈ
Clinically Proven Results
Clinical trials showed average weight loss of 15-20% of body weight over 72 weeks. Combined with FRAME’s nutrition guidance, results can be significantly accelerated.
🍽️
Appetite & Hunger Control
Reduces hunger signals and slows gastric emptying, making it easier to eat less without feeling deprived. Most patients report dramatically reduced cravings within weeks.
🩸
Metabolic Benefits
Beyond weight loss, tirzepatide improves blood sugar regulation, insulin sensitivity, and cardiovascular markers β€” a meaningful benefit for men with metabolic syndrome.
πŸ“¦
Compounded & Affordable
Brand-name tirzepatide (Mounjaro) can cost $1,000+/month without insurance. FRAME’s compounded tirzepatide delivers the same active ingredient at a fraction of the cost.
🩺
Physician-Managed
Dr. Sheffield manages your entire treatment β€” titration schedule, side effect monitoring, dosing adjustments. Not a subscription service. A medical relationship.
Tirzepatide vs. Semaglutide

Which Is Right
For You?

Both are effective GLP-1 medications. The right choice depends on your health history, goals, and how your body responds. Dr. Sheffield makes this call based on your labs and a full clinical picture — not a quiz.

Also available at FRAME
Semaglutide
Single GLP-1 receptor activation
Effective weight loss (10-15% average in trials)
Good tolerability profile, well-established
From $46/week at FRAME
Lower average weight loss than tirzepatide head-to-head
Pricing

No Surprises.
No Hidden Fees.

GLP-1 Therapy
Tirzepatide Monthly Plan
$69
per
week
Billed at $300 / month
  • Compounded tirzepatide from a licensed pharmacy
  • All supplies included β€” needles, syringes, alcohol swabs
  • Discreet, unmarked shipping to your door
  • Physician access throughout treatment
  • Nutrition & lifestyle guidance included
  • Dose titration and adjustments as needed
  • Follow-up labs at clinically appropriate intervals
Initial Evaluation

$100 covers your first lab panel and Dr. Sheffield’s full review. Required before starting β€” one-time, separate from monthly membership.

Tirzepatide + Testosterone

Men on both TRT and tirzepatide save with our combination plan at $400/month ($92/week). Ask about this during your evaluation.

No Insurance Required

All services are direct-pay. No prior authorizations. No surprise bills. Transparent from day one.

Start with Labs — $100 Compare Semaglutide
Licensed in FL • GA • WA • NE • NC
Your Physician

Managed by a
Real Doctor

Dr. Colin Sheffield DO - FRAME Medicine
Medical Director • Board-Certified Family Medicine, DO
Dr. Colin
Sheffield

GLP-1 therapy is powerful β€” and it requires real physician oversight. Dr. Sheffield manages every tirzepatide patient personally. Titration decisions, dosing adjustments, and lab monitoring are clinical decisions made by a board-certified physician, not automated by an algorithm.

He’s the same physician you’ll work with for the life of your treatment at FRAME. No handoffs. No call centers. No guessing.

Start Your Evaluation
Questions

Tirzepatide FAQ

Clinical trials showed tirzepatide patients losing an average of 15-20% of body weight over 72 weeks. Results vary based on dose, adherence, diet, and activity. FRAME includes nutrition and lifestyle guidance to help you get the most out of treatment.

The most common side effects are GI-related: nausea, constipation, diarrhea, and reduced appetite β€” particularly when starting or titrating up. These typically subside as your body adjusts. Dr. Sheffield manages your titration schedule specifically to minimize side effects.

Compounded tirzepatide contains the same active ingredient as Mounjaro. It is produced by a licensed compounding pharmacy and is not FDA-approved as a finished drug product, but the active molecule is identical. FRAME only works with licensed, inspected compounding pharmacies.

Tirzepatide is administered via subcutaneous (under the skin) self-injection, typically once weekly. All supplies are shipped with your medication. Dr. Sheffield will walk you through proper technique β€” most patients are comfortable within their first injection.

Yes. Many FRAME patients are on both. The combination is clinically complementary β€” TRT helps preserve muscle mass while tirzepatide drives fat loss. FRAME offers a combination plan at $400/month. Dr. Sheffield will evaluate whether it’s appropriate for you.

Duration is a clinical decision. Some patients use tirzepatide until they reach their goal and transition off with a supervised plan. Others continue long-term for weight maintenance. Dr. Sheffield will guide this decision based on your response, labs, and goals.

Ready to Start
Losing Weight?

$100 covers your labs and physician review. Real answers in 7-10 days.